Hmmm two institutional investors from overseas seem to differ from "take profits" - one is from Harvard Uni in the USA and the other from the Church of England in England. Hardly likely to take a punt without due diligence - if they re happy campers I am happy to stay the ride.
Do not forget the barrier to entry for a competitor is very high i.e. 14 15 years high and the market they are addressing i.e. warts and acne has a recurring sales potential i.e. teenagers.
IMO and DYOR of course
Ann: TFS Delivers Record Half Year Profit and Upgrades Guidance, page-8
Add to My Watchlist
What is My Watchlist?